The Mesothelioma Options Help Center supports the FDA's approval of Opdivo in combination with Yervoy
The Mesothelioma Options Help Center supports the FDA's approval of Opdivo in combination with Yervoy
The most common side effects of Opdivo in combination with Yervoy in patients with malignant pleural mesothelioma include: fatigue, musculoskeletal pain, rash, diarrhea, dyspnea (difficulty breathing), nausea, decreased appetite, cough and pruritis (itching). Yervoy can cause serious conditions known as immune-mediated side effects, including inflammation of healthy organs, such as the lungs (pneumonitis), colon (colitis), liver (hepatitis), endocrine glands (endocrinopathies) and kidneys (nephritis). Patients should tell their healthcare providers if they have immune system problems, lung or breathing problems, liver problems, have had an organ transplant, or are pregnant or plan to become pregnant before starting treatment.
Robert L. Steinberg
Mesothelioma Options Help Center
+1 888-891-2200
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
1 http://mesotheliomaoptions.com/contact/
2 http://mesotheliomaoptions.com/contact/
3 http://mesotheliomaoptions.com/contact/